These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8118118)

  • 1. The intrapleural administration of recombinant interleukin-2 (rIL-2) to patients with malignant pleural effusion: clinical trials.
    Suzuki H; Abo S; Kitamura M; Hashimoto M; Izumi K
    Surg Today; 1993; 23(12):1053-9. PubMed ID: 8118118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental and clinical studies on intrapleural instillations of interleukin-2 (IL-2) in patients with malignant pleural effusion].
    Suzuki H
    Nihon Geka Gakkai Zasshi; 1989 Nov; 90(11):1922-31. PubMed ID: 2608022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intrapleural transfer of LAK cells combined with rIL-2 in the treatment of advanced lung cancer with malignant pleural effusion].
    Li DJ
    Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):294-6. PubMed ID: 2625114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intrapleural administration of LAK cells combined with rIL2 in the treatment of advanced lung cancer with malignant pleural effusion].
    Mao G; Gao Z; Wang Q
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Apr; 18(2):83-4, 127. PubMed ID: 7553956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of treatment with transfer of autologous or allogenic LAK cells combined with rIL-2 in 121 patients with malignant pleural effusion].
    Liu X
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):205-8. PubMed ID: 8261867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of intrapleural recombinant interleukin-2 in immunotherapy for malignant pleural effusion.
    Astoul P; Bertault-Peres P; Durand A; Catalin J; Vignal F; Boutin C
    Cancer; 1994 Jan; 73(2):308-13. PubMed ID: 8293393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of lymphokine-activated killer cells by intrapleural instillations of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer.
    Yasumoto K; Mivazaki K; Nagashima A; Ishida T; Kuda T; Yano T; Sugimachi K; Nomoto K
    Cancer Res; 1987 Apr; 47(8):2184-7. PubMed ID: 3493843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of 121 patients with malignant effusion due to advanced lung cancer by intrapleural transfer of autologous or allogeneic LAK cells combined with rIL-2.
    Liu X; Li D; Zhang C; Ba D; Liu J; Wan T; Li Z; Jin Y; He Y
    Chin Med Sci J; 1993 Sep; 8(3):186-9. PubMed ID: 8142637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new approach to the treatment of malignant effusion.
    Li DJ; Wang YR; Tan XY; Wang HZ; Yao XD; Ba DN
    Chin Med J (Engl); 1990 Dec; 103(12):998-1002. PubMed ID: 2127253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapleural recombinant IL-2 in passive immunotherapy for malignant pleural effusion.
    Astoul P; Viallat JR; Laurent JC; Brandely M; Boutin C
    Chest; 1993 Jan; 103(1):209-13. PubMed ID: 8417880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypes and lymphokine-activated killer activity of pleural cavity lymphocytes of lung cancer patients without malignant effusion.
    Takahashi K; Sone S; Kimura S; Ogura T; Monden Y
    Chest; 1993 Jun; 103(6):1732-8. PubMed ID: 8404092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of intraperitoneal recombinant interleukin-2/lymphokine-activated killer cells in patients with ovarian cancer.
    Stewart JA; Belinson JL; Moore AL; Dorighi JA; Grant BW; Haugh LD; Roberts JD; Albertini RJ; Branda RF
    Cancer Res; 1990 Oct; 50(19):6302-10. PubMed ID: 2205379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Induction by local injections of IL-2 of antitumor effector cells and secondary production of cytokines in malignant pleural effusion].
    Sone S; Yanagawa H; Nii A; Ozaki T; Ogura T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug; 30(8):1434-40. PubMed ID: 1434216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local adoptive immunotherapy using lymphokine-activated killer cells and interleukin-2 against malignant pleural mesothelioma: report of two cases.
    Yanagawa H; Sone S; Fukuta K; Nishioka Y; Ogura T
    Jpn J Clin Oncol; 1991 Oct; 21(5):377-83. PubMed ID: 1753419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study.
    Goey SH; Eggermont AM; Punt CJ; Slingerland R; Gratama JW; Oosterom R; Oskam R; Bolhuis RL; Stoter G
    Br J Cancer; 1995 Nov; 72(5):1283-8. PubMed ID: 7577483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphokine-activated killer induction and its regulation by macrophages in malignant pleural effusions.
    Yanagawa H; Sone S; Nii A; Fukuta K; Nakanishi M; Maeda K; Honda M; Ogura T
    Jpn J Cancer Res; 1989 Dec; 80(12):1220-7. PubMed ID: 2516849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrapleural application of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer. A multi-institutional cooperative study.
    Yasumoto K; Ogura T
    Biotherapy; 1991; 3(4):345-9. PubMed ID: 1786198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrapleural administration of interleukin-2 and LAK cells in locally advanced non-small-cell lung cancer. A case report.
    Matteucci P; Tresoldi M; Chiesa G; Tognella S; Citterio G; Fortis C; Besana C; Rugarli C
    Tumori; 1994 Jun; 80(3):246-50. PubMed ID: 8053086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Colony-stimulating factor activity in malignant pleural effusions and its augmentation by local administration of interleukin 2].
    Nakanishi M; Sone S; Ogura T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jul; 29(7):824-8. PubMed ID: 1920977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-macrophage colony-stimulating factor augments lymphokine-activated killer activity from pleural cavity mononuclear cells of lung cancer patients without malignant effusion.
    Takahashi K; Sone S; Saito S; Kamamura Y; Uyama T; Ogura T; Monden Y
    Jpn J Cancer Res; 1995 Sep; 86(9):861-6. PubMed ID: 7591964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.